MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-13-2025
Check-Cap Ltd. Total Shareholders Equity 2011-2025 | CHEK
Annual Total Shareholders Equity Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.45 M | 23.7 M | 41.3 M | 50.7 M | 16.4 M | 6.23 M | 13 M | 5.9 M | 10.4 M | 12.6 M | -826 K | -528 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.7 M | -1.45 M | 14.8 M |
Quarterly Total Shareholders Equity Check-Cap Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 50.7 M | - | 28.3 M | 32.1 M | 16.4 M | - | 15 M | 7.66 M | 6.23 M | - | 13.3 M | 16.5 M | 13 M | - | 18.5 M | 3.34 M | 5.9 M | - | 7.63 M | - | 10.4 M | - | 8.72 M | - | 12.6 M | - | 17.7 M | - | -826 K | - | - | - | -528 K | - | - | - | 2.78 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 50.7 M | -826 K | 13.6 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
19.6 M | $ 16.75 | -1.28 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 16.9 | 7.3 % | $ 183 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.4 M | $ 1.57 | -3.08 % | $ 2 M | USA |
 |
Castle Biosciences
CSTL
|
456 M | $ 38.44 | -0.5 % | $ 1.07 B | USA |
 |
DarioHealth Corp.
DRIO
|
58.1 M | $ 12.0 | 0.93 % | $ 340 M | Israel |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
2.07 B | $ 66.39 | -0.85 % | $ 25.6 B | USA |
 |
Danaher Corporation
DHR
|
49.5 B | $ 226.5 | - | $ 166 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | $ 101.57 | 0.07 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 26.81 | -1.22 % | $ 811 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
261 M | $ 19.74 | -3.99 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
116 M | $ 102.0 | -3.09 % | $ 4.02 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
20 M | $ 3.53 | -1.4 % | $ 113 K | USA |
 |
Co-Diagnostics
CODX
|
86 M | $ 0.31 | -9.4 % | $ 9.1 M | USA |
 |
IQVIA Holdings
IQV
|
6.07 B | $ 222.3 | 0.04 % | $ 40.3 B | USA |
 |
Guardant Health
GH
|
-140 M | $ 103.47 | 1.37 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
6.73 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 133.88 | -0.73 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
3.46 B | $ 196.14 | 1.64 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
-35.6 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
6.78 B | $ 183.36 | 0.47 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
20.9 M | $ 7.56 | -3.63 % | $ 980 M | USA |
 |
Mettler-Toledo International
MTD
|
-127 M | $ 1 410.24 | 1.17 % | $ 29.9 B | Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
8.05 B | $ 262.29 | -0.71 % | $ 22 B | USA |
 |
Myriad Genetics
MYGN
|
701 M | $ 7.01 | -2.84 % | $ 635 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 183.39 | -1.71 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.6 B | $ 701.16 | -0.43 % | $ 57.8 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 67.34 | 1.08 % | $ 4.66 B | USA |
 |
NeoGenomics
NEO
|
902 M | $ 12.07 | 1.81 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 6.8 | -0.95 % | $ 1.47 B | USA |
 |
Agilent Technologies
A
|
5.39 B | $ 140.63 | 0.69 % | $ 42.8 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.56 | 0.29 % | $ 5.88 M | USA |
 |
Bioventus
BVS
|
174 M | $ 7.59 | 0.53 % | $ 475 M | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |